vs

Side-by-side financial comparison of National Bank Holdings Corp (NBHC) and Organogenesis Holdings Inc. (ORGO). Click either name above to swap in a different company.

Organogenesis Holdings Inc. is the larger business by last-quarter revenue ($225.6M vs $126.8M, roughly 1.8× National Bank Holdings Corp). Organogenesis Holdings Inc. runs the higher net margin — 19.4% vs 16.4%, a 3.0% gap on every dollar of revenue. Over the past eight quarters, Organogenesis Holdings Inc.'s revenue compounded faster (43.2% CAGR vs 14.0%).

Old National Bank is an American regional bank with nearly 200 retail branches operated by Old National Bancorp and based in Chicago and Evansville, Indiana. With assets at $48.5 billion and 250 banking centers, Old National Bancorp is the largest financial services bank holding company headquartered in Indiana and one of the top 30 banking companies in the U.S. Old National Bank has locations in Illinois, Indiana, Iowa, Kentucky, Michigan, Minnesota, Tennessee, and Wisconsin.

Organogenesis Holdings Inc. is a leading regenerative medicine firm specializing in developing and manufacturing advanced therapeutic products for wound care, surgical repair, sports medicine, and dermatology. It serves healthcare providers and patients primarily in the U.S. and select international markets, offering clinically validated solutions for unmet medical needs.

NBHC vs ORGO — Head-to-Head

Bigger by revenue
ORGO
ORGO
1.8× larger
ORGO
$225.6M
$126.8M
NBHC
Higher net margin
ORGO
ORGO
3.0% more per $
ORGO
19.4%
16.4%
NBHC
Faster 2-yr revenue CAGR
ORGO
ORGO
Annualised
ORGO
43.2%
14.0%
NBHC

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
NBHC
NBHC
ORGO
ORGO
Revenue
$126.8M
$225.6M
Net Profit
$20.8M
$43.7M
Gross Margin
Operating Margin
28.1%
Net Margin
16.4%
19.4%
Revenue YoY
78.1%
Net Profit YoY
-14.2%
469.5%
EPS (diluted)
$0.46
$0.31

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
NBHC
NBHC
ORGO
ORGO
Q1 26
$126.8M
Q4 25
$100.6M
$225.6M
Q3 25
$108.9M
$150.9M
Q2 25
$104.5M
$101.0M
Q1 25
$102.1M
$86.7M
Q4 24
$101.3M
$126.7M
Q3 24
$106.0M
$115.2M
Q2 24
$97.6M
$130.2M
Net Profit
NBHC
NBHC
ORGO
ORGO
Q1 26
$20.8M
Q4 25
$16.0M
$43.7M
Q3 25
$35.3M
$21.6M
Q2 25
$34.0M
$-9.4M
Q1 25
$24.2M
$-18.8M
Q4 24
$28.2M
$7.7M
Q3 24
$33.1M
$12.3M
Q2 24
$26.1M
$-17.0M
Gross Margin
NBHC
NBHC
ORGO
ORGO
Q1 26
Q4 25
Q3 25
Q2 25
Q1 25
72.6%
Q4 24
75.5%
Q3 24
76.7%
Q2 24
77.6%
Operating Margin
NBHC
NBHC
ORGO
ORGO
Q1 26
Q4 25
19.0%
28.1%
Q3 25
39.6%
13.7%
Q2 25
39.8%
-12.5%
Q1 25
29.2%
-30.9%
Q4 24
34.3%
8.1%
Q3 24
37.6%
5.4%
Q2 24
32.5%
-10.7%
Net Margin
NBHC
NBHC
ORGO
ORGO
Q1 26
16.4%
Q4 25
15.9%
19.4%
Q3 25
32.4%
14.3%
Q2 25
32.6%
-9.3%
Q1 25
23.7%
-21.7%
Q4 24
27.8%
6.1%
Q3 24
31.2%
10.7%
Q2 24
26.8%
-13.1%
EPS (diluted)
NBHC
NBHC
ORGO
ORGO
Q1 26
$0.46
Q4 25
$0.42
$0.31
Q3 25
$0.92
$0.11
Q2 25
$0.88
$-0.10
Q1 25
$0.63
$-0.17
Q4 24
$0.72
$0.05
Q3 24
$0.86
$0.09
Q2 24
$0.68
$-0.13

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
NBHC
NBHC
ORGO
ORGO
Cash + ST InvestmentsLiquidity on hand
$472.8M
$93.7M
Total DebtLower is stronger
$202.1M
Stockholders' EquityBook value
$1.7B
$300.1M
Total Assets
$12.6B
$598.7M
Debt / EquityLower = less leverage
0.12×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
NBHC
NBHC
ORGO
ORGO
Q1 26
$472.8M
Q4 25
$417.1M
$93.7M
Q3 25
$555.6M
$63.7M
Q2 25
$296.5M
$73.1M
Q1 25
$246.3M
$110.0M
Q4 24
$127.8M
$135.6M
Q3 24
$180.8M
$94.3M
Q2 24
$145.0M
$89.9M
Total Debt
NBHC
NBHC
ORGO
ORGO
Q1 26
$202.1M
Q4 25
$54.5M
Q3 25
$54.7M
Q2 25
$54.4M
Q1 25
$54.6M
Q4 24
$54.5M
Q3 24
$54.4M
$62.3M
Q2 24
$54.4M
$63.8M
Stockholders' Equity
NBHC
NBHC
ORGO
ORGO
Q1 26
$1.7B
Q4 25
$1.4B
$300.1M
Q3 25
$1.4B
$255.1M
Q2 25
$1.4B
$233.2M
Q1 25
$1.3B
$242.9M
Q4 24
$1.3B
$262.9M
Q3 24
$1.3B
$278.5M
Q2 24
$1.2B
$263.5M
Total Assets
NBHC
NBHC
ORGO
ORGO
Q1 26
$12.6B
Q4 25
$9.9B
$598.7M
Q3 25
$10.2B
$509.8M
Q2 25
$10.0B
$461.1M
Q1 25
$10.1B
$467.4M
Q4 24
$9.8B
$497.9M
Q3 24
$10.0B
$446.3M
Q2 24
$10.0B
$443.2M
Debt / Equity
NBHC
NBHC
ORGO
ORGO
Q1 26
0.12×
Q4 25
0.04×
Q3 25
0.04×
Q2 25
0.04×
Q1 25
0.04×
Q4 24
0.04×
Q3 24
0.04×
0.22×
Q2 24
0.04×
0.24×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
NBHC
NBHC
ORGO
ORGO
Operating Cash FlowLast quarter
$39.4M
Free Cash FlowOCF − Capex
$34.8M
FCF MarginFCF / Revenue
15.4%
Capex IntensityCapex / Revenue
2.1%
Cash ConversionOCF / Net Profit
0.90×
TTM Free Cash FlowTrailing 4 quarters
$-24.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
NBHC
NBHC
ORGO
ORGO
Q1 26
Q4 25
$162.4M
$39.4M
Q3 25
$52.4M
$3.1M
Q2 25
$32.3M
$-32.9M
Q1 25
$39.6M
$-19.9M
Q4 24
$155.3M
$10.9M
Q3 24
$47.0M
$8.7M
Q2 24
$31.9M
$4.7M
Free Cash Flow
NBHC
NBHC
ORGO
ORGO
Q1 26
Q4 25
$34.8M
Q3 25
$844.0K
Q2 25
$-36.5M
Q1 25
$-23.6M
Q4 24
$7.6M
Q3 24
$6.1M
Q2 24
$2.9M
FCF Margin
NBHC
NBHC
ORGO
ORGO
Q1 26
Q4 25
15.4%
Q3 25
0.6%
Q2 25
-36.1%
Q1 25
-27.2%
Q4 24
6.0%
Q3 24
5.3%
Q2 24
2.2%
Capex Intensity
NBHC
NBHC
ORGO
ORGO
Q1 26
Q4 25
2.1%
Q3 25
1.5%
Q2 25
3.6%
Q1 25
4.2%
Q4 24
2.7%
Q3 24
2.2%
Q2 24
1.4%
Cash Conversion
NBHC
NBHC
ORGO
ORGO
Q1 26
Q4 25
10.13×
0.90×
Q3 25
1.48×
0.14×
Q2 25
0.95×
Q1 25
1.64×
Q4 24
5.51×
1.43×
Q3 24
1.42×
0.71×
Q2 24
1.22×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

NBHC
NBHC

Net Interest Income$108.8M86%
Noninterest Income$18.0M14%

ORGO
ORGO

Segment breakdown not available.

Related Comparisons